I won't diluteshareholdersNot manycompaniesthis size with2 late stageassetsThere are noFDAapproveddrugs to treathemorrhoidsThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We expect tofinish theMino-Loktrial this yearI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Mino-Lokis our leadassetMino-WrapI/ONTAK'spotentialmarket is>$300mWe intendto submita BLA in2H 2022An actualiMSCupdateInsidersinvested$26.5mOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKis our leadassetWe had aphase 2btrial with100%efficacyWe willhaveexclusivityMyron Holubiakand I founded aprivatecompany in2013We will openupinternationalsites forMino-Lok trialHemorrhoidsis a $2BmarketI'm ashareholdermyselfMino-Lokpotentialmarket>$1BOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAKwas thebest deal Iever madeWe haveenough cashto go wellinto 2023I won't diluteshareholdersNot manycompaniesthis size with2 late stageassetsThere are noFDAapproveddrugs to treathemorrhoidsThe name Citiuscomes from theOlympic motto"Citius,AltiusForius"We expect tofinish theMino-Loktrial this yearI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Mino-Lokis our leadassetMino-WrapI/ONTAK'spotentialmarket is>$300mWe intendto submita BLA in2H 2022An actualiMSCupdateInsidersinvested$26.5mOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKis our leadassetWe had aphase 2btrial with100%efficacyWe willhaveexclusivityMyron Holubiakand I founded aprivatecompany in2013We will openupinternationalsites forMino-Lok trialHemorrhoidsis a $2BmarketI'm ashareholdermyselfMino-Lokpotentialmarket>$1BOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAKwas thebest deal Iever madeWe haveenough cashto go wellinto 2023

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I won't dilute shareholders
  2. Not many companies this size with 2 late stage assets
  3. There are no FDA approved drugs to treat hemorrhoids
  4. The name Citius comes from the Olympic motto "Citius,Altius Forius"
  5. We expect to finish the Mino-Lok trial this year
  6. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  7. Mino-Lok is our lead asset
  8. Mino-Wrap
  9. I/ONTAK's potential market is >$300m
  10. We intend to submit a BLA in 2H 2022
  11. An actual iMSC update
  12. Insiders invested $26.5m
  13. Only biotech with 2 Myron's on the leadership team
  14. I/ONTAK is our lead asset
  15. We had a phase 2b trial with 100% efficacy
  16. We will have exclusivity
  17. Myron Holubiak and I founded a private company in 2013
  18. We will open up international sites for Mino-Lok trial
  19. Hemorrhoids is a $2B market
  20. I'm a shareholder myself
  21. Mino-Lok potential market >$1B
  22. Our Halo-Lido trial will have final patient by end of 2022
  23. I/ONTAK was the best deal I ever made
  24. We have enough cash to go well into 2023